[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100337540":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":23,"centralContacts":27,"locations":18,"responsibleParty":32,"collaborators":18,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":40,"acronym":18,"eligibilityCriteria":41,"healthyVolunteers":37,"sex":42,"minAge":43,"maxAge":18,"enrollmentInfo":44,"targetDuration":18,"studyType":47,"phases":48,"briefSummary":50,"conditions":51,"keywords":18,"overallStatus":53,"whyStopped":18,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":18},{"fullName":5,"class":6},"Seattle Children's Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Group Providers","ACTIVE_COMPARATOR","DART QI Program Participation",[13],"Other: DART QI Program Participation",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group Providers","NO_INTERVENTION","Usual Care",null,[20],{"type":6,"name":11,"description":21,"armGroupLabels":22,"otherNames":18},"Antibiotic prescribing data will be collected at multiple time points both before and after the initiation of the intervention.",[9],[24],{"name":25,"affiliation":5,"role":26},"Rita Mangione-Smith, MD, MPH","PRINCIPAL_INVESTIGATOR",[28],{"name":25,"role":29,"phone":30,"phoneExt":18,"email":31},"CONTACT","206-884-8242","Rita.Mangione-Smith@seattlechildrens.org",{"type":26,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Rita Mangione-Smith","Professor and Chief","100337540","reducing-antibiotic-prescribing-in-family-practice-100337540",false,"NCT03674775","Reducing Antibiotic Prescribing in Family Practice","Dialogue Around Respiratory Illness Treatment for Family Practice (DART -FP)","Inclusion Criteria:\n\n1. Children or adults with acute respiratory tract infections (ARTIs) defined as bacterial (acute otitis media \\[AOM\\], pharyngitis, and sinusitis) or viral (bronchitis and viral upper respiratory infection \\[URI\\]) based on their common etiologies.\n2. Seven months old and older\n\nExclusion Criteria:\n\n1\\. 0 - 6 months old","ALL","6 Months",{"count":45,"type":46},180,"ESTIMATED","INTERVENTIONAL",[49],"NA","Antibiotic prescribing for childhood acute respiratory tract infections (ARTIs), including acute otitis media (AOM), pharyngitis, sinusitis, bronchitis, and upper respiratory infection (URI), is common in the United States (US). In the outpatient setting, more than 50% of children diagnosed with ARTIs receive antibiotic prescriptions. Considering that the estimated US prevalence of pediatric bacterial ARTIs is 27% (with the remainder of ARTIs caused by viruses) this represents a substantial degree of antibiotic overuse nationwide. Another troubling trend in antibiotic prescribing for ARTIs in children is the increased reliance on broad-spectrum, second-line agents for bacterial ARTIs. Unwarranted use of antibiotics, especially broad-spectrum agents, has been associated with increased resistance among several strains of bacteria that commonly cause ARTIs, posing risks to both individuals and communities.",[52],"Acute Respiratory Tract Infection","NOT_YET_RECRUITING","2019-09-17",{"date":56,"type":57},"2019-09-19","ACTUAL",{"date":59,"type":46},"2022-07",{"date":61,"type":46},"2026-06",{"name":5,"class":6}]